Josée Golay Selected Research

Josée Golay Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 08/2003
11	Lymphoma (Lymphomas) 09/2023 - 08/2003
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 04/2009
3	Multiple Myeloma 02/2024 - 02/2010
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2023 - 04/2010
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 07/2007
3	Leukemia 01/2018 - 04/2010
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2015 - 05/2008
1	Type 2 Diabetes Mellitus (MODY) 10/2023
1	Chronic Renal Insufficiency 10/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2022
1	Infections 01/2022
1	Infertility (Sterility) 01/2022
1	Melanoma (Melanoma, Malignant) 05/2020
1	Autoimmune Diseases (Autoimmune Disease) 12/2017
1	Graves Ophthalmopathy 01/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2011
1	Hematologic Neoplasms (Hematological Malignancy) 04/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2010
1	Inflammation (Inflammations) 05/2008
1	B-Cell Leukemia (Leukemia, B Cell) 12/2004
1	Prolymphocytic Leukemia 12/2004
1	Hairy Cell Leukemia 12/2004
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 05/2003

Drug/Important Bio-Agent (IBA)

17	Rituximab (Mabthera)FDA Link 01/2022 - 05/2003
10	AntibodiesIBA 01/2022 - 12/2004
6	Monoclonal AntibodiesIBA 10/2020 - 01/2011
4	Immunoglobulin G (IgG)IBA 01/2022 - 12/2017
4	Complement System Proteins (Complement)IBA 01/2022 - 05/2007
4	CytokinesIBA 01/2011 - 07/2007
3	blinatumomabIBA 01/2022 - 11/2014
2	B-Cell Maturation AntigenIBA 02/2024 - 11/2023
2	Immune Checkpoint InhibitorsIBA 02/2024 - 05/2020
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 02/2024 - 11/2023
2	AntigensIBA 01/2022 - 10/2020
2	Agammaglobulinaemia Tyrosine KinaseIBA 10/2017 - 01/2015
2	givinostatIBA 03/2013 - 08/2012
2	ofatumumab FDA Link 01/2013 - 12/2011
2	Histone Deacetylase InhibitorsIBA 08/2012 - 02/2010
2	Alemtuzumab (Campath)FDA Link 03/2011 - 12/2004
2	Proteins (Proteins, Gene)FDA Link 02/2010 - 05/2007
2	ChemokinesIBA 05/2008 - 05/2007
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2023
1	Chimeric Antigen ReceptorsIBA 09/2023
1	FucoseIBA 01/2022
1	EndotoxinsIBA 01/2022
1	Blocking AntibodiesIBA 05/2020
1	SteroidsIBA 01/2020
1	acalabrutinibIBA 10/2017
1	ibrutinibIBA 01/2015
1	idelalisibIBA 01/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2013
1	obinutuzumabIBA 11/2013
1	Hydroxyurea (Hydrea)FDA LinkGeneric 03/2013
1	fludarabineIBA 01/2013
1	Immunomodulating AgentsIBA 10/2012
1	Transcription Factors (Transcription Factor)IBA 08/2012
1	Janus Kinase 2IBA 08/2012
1	Complement Receptors (Complement Receptor)IBA 12/2011
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 09/2011
1	LigandsIBA 09/2011
1	N- (6,6- dimethyl- 5- ((1- methylpiperidin- 4- yl)carbonyl)- 1,4,5,6- tetrahydropyrrolo(3,4- c)pyrazol- 3- yl)- 3- methylbutanamideIBA 04/2010
1	givinostat hydrochlorideIBA 02/2010
1	MicroRNAs (MicroRNA)IBA 02/2010
1	Interleukin-10 (Interleukin 10)IBA 04/2009
1	Conditioned Culture MediaIBA 04/2009
1	cobra venom factorIBA 05/2007
1	CC ChemokinesIBA 05/2007
1	Therapeutic UsesIBA 03/2005
1	Complementary DNA (cDNA)IBA 08/2003

Therapy/Procedure

3	Therapeutics 10/2023 - 01/2011
3	Drug Therapy (Chemotherapy) 05/2020 - 07/2007
2	Immunotherapy 05/2020 - 05/2009
2	Radiotherapy 05/2020 - 07/2007
1	Hematopoietic Stem Cell Transplantation 01/2020
1	Transplantation 11/2010
1	Salvage Therapy 07/2007